Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.68 USD | +0.01% | +5.47% | +5.03% |
12:35pm | Morgan Stanley Adjusts Exelon's Price Target to $38 From $37, Keeps Equalweight Rating | MT |
Apr. 22 | Scotiabank Adjusts Exelon's Price Target to $37 From $39 | MT |
Financials (USD)
Sales 2024 * | 21.24B | Sales 2025 * | 22B | Capitalization | 37.66B |
---|---|---|---|---|---|
Net income 2024 * | 2.45B | Net income 2025 * | 2.64B | EV / Sales 2024 * | 3.94 x |
Net Debt 2024 * | 46.02B | Net Debt 2025 * | 48.82B | EV / Sales 2025 * | 3.93 x |
P/E ratio 2024 * |
15.4
x | P/E ratio 2025 * |
14.4
x | Employees | 19,962 |
Yield 2024 * |
4.1% | Yield 2025 * |
4.34% | Free-Float | 99.67% |
Latest transcript on Exelon Corporation
1 day | +0.17% | ||
1 week | +4.92% | ||
Current month | -0.16% | ||
1 month | +1.79% | ||
3 months | +7.94% | ||
6 months | -2.32% | ||
Current year | +4.48% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.58% | 1 M€ | -.--% | - | |
2.45% | 610 M€ | -0.89% | ||
1.56% | 18 M€ | +2.56% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 37.7 | +0.09% | 2 338 277 |
24-04-22 | 37.67 | +0.32% | 5,174,426 |
24-04-19 | 37.55 | +2.37% | 6,126,503 |
24-04-18 | 36.68 | +0.71% | 4,395,547 |
24-04-17 | 36.42 | +1.87% | 4,716,914 |
Delayed Quote Nasdaq, April 23, 2024 at 09:38 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.48% | 37.66B | |
+10.26% | 134B | |
+3.86% | 79.81B | |
-3.20% | 76.68B | |
+1.21% | 75.7B | |
+57.63% | 57.74B | |
+4.50% | 44.71B | |
+7.53% | 42.41B | |
0.00% | 37.19B | |
-5.82% | 36.22B |
- Stock Market
- Equities
- EXC Stock